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This thematic series is concerned with various ways Evo-
lution is intertwined with cancer. A group of cancer
researchers and mathematical modelers, with an interest
in the subject, was invited to contribute papers on topics
ranging from carcinogenesis through progression of can-
cer through therapy. The resulting collection of ten
papers is briefly introduced below. Publication of the
series was planned to coincide with Darwin's Year, 2009,
however various obstacles delayed publication.
Mathematical modeling of processes related to cancer
evolution has come of age. What used to be a mathemati-
cal metaphor or speculation, has become progressively
more infused with genetic and biological details and is
reconcilable with epidemiology of a given cancer. The
seminal biological discoveries, which lead to paradigm
changes in modeling, include the concept of canceriza-
tion field, which puts into question the clonal carcinogen-
esis. Another set of discoveries includes genes with key
roles in the regulation of DNA repair and genome expres-
sion that are often mutated in cancers, such as BRCA1,
BRCA2 or P53, and understanding signaling pathways
disrupted by mutations in these genes. Still another cate-
gory of findings concerns tumor metabolism, which
includes cell functioning under anoxic conditions. Finally,
the understanding of structural issues such as vascular-
ization of solid tumors, mechanisms of metastasis and
invasion and emergence of resistance brought a totally
different perspective on modeling of cancer growth and
progression. In all these processes, well-known evolu-
tionary forces such as mutation and selection play major
roles. They are modulated and channeled both by the
natural environment in which tumors exist, but also by
medical intervention.
A review of current work on modeling of the role evolu-
tion plays in cancer is the subject of the Thematic Series.
We briefly review the papers, assigning them idiosyncrat-
ically to 3 different categories.
Carcinogenesis, evolution and emergence of cancer
The opening paper by Little [1] is a critical review of biol-
ogy of cancer and argues based on evidence adduced that
its development can be modeled as a somatic cellular
Darwinian evolutionary process. A variety of quasi-
mechanistic models of carcinogenesis are reviewed, all
based on this somatic Darwinian evolutionary hypothe-
sis; in particular, the multi-stage model of Armitage and
Doll, the two-mutation model of Moolgavkar, Venzon,
and Knudson (MVK), the generalized MVK model of Lit-
tle and various further generalizations of these incorpo-
rating effects of genomic instability.
Following these basically clonal models, the paper by
Agur et al. [2] discusses tumorigenesis as triggered by dis-
ruption of a quorum sensing mechanism, using a simple
discrete model corroborated by experiments in mam-
mary cancer stem cells. Application of this theory to a
cellular automata model of stem cell development in dis-
rupted environments, shows a sharply dichotomous
growth dynamics: maturation within 50-400 cell-cycles,
or immortalization. This dichotomy is mainly driven by
intercellular communication, low values of which cause
perpetual proliferation.
The subsequent contribution by Thalhauser et al. [3]
shifts emphasis to selection in spatial stochastic models
of cancer. The thesis is that migration is a key modulator
of fitness. To study the selection dynamics in a heteroge-
neous spatial colony of cells, they use two spatial general-
izations of the Moran process, which include cell
divisions, death and migration. They find that repeated
instances of large scale cell-death, such as might arise
during therapeutic intervention or host response,
strongly select for the migratory phenotype. The models
help to explain how chemotherapy may provide a selec-
tion mechanism for highly invasive phenotypes.
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This section contains works involved with evolutionary
forces in later stages of cancer natural course. Smallbone
et al. [4] study how episodic, transient systemic acidosis
delays evolution of the malignant phenotype. The transi-
tion from premalignant to invasive tumour growth is a
prolonged multistep process governed by phenotypic
adaptation to changing microenvironmental selection
pressures. Model simulations demonstrate that repeated
episodes of transient systemic acidosis will interrupt crit-
ical evolutionary steps in the later stages of carcinogene-
sis resulting in substantial delay in the evolution to the
invasive phenotype. The results suggest transient sys-
temic acidosis may mediate the observed reduction in
cancer risk associated with increased physical activity.
Enderling et al. [5] study tumor morphological evolu-
tion: directed migration and gain and loss of the self-met-
astatic phenotype. Considering only the properties of
random migration in tumors composed of stem cells and
committed cells, they recapitulate a characteristic clus-
tering feature of invasive tumor growth, a property they
attribute to "self-metastatic" growth. Furthermore,
directed migration will result in loss of the invasive phe-
notype as the tumor approaches the attractor source.
Eikenberry et al. [6] consider the evolutionary impact
of androgen levels on prostate cancer in a multi-scale
mathematical model. Their results suggest that an aber-
rant androgen environment may delay progression to a
malignant phenotype, but result in a more dangerous
cancer should one arise. The model represents an initial
framework for understanding the role of androgens in
prostate cancer etiology, and it suggests that low andro-
gen levels can increase selection for phenotypes resistant
to hormonal therapy that may also be more aggressive.
Moreover, clinical treatment with 5α-reductase inhibitors
may increase the incidence of therapy resistant cancers.
Silva and Gatenby [7] present a theoretical quantitative
model for evolution of cancer chemotherapy resistance.
They propose that in order to understand the evolution-
ary dynamics that allow tumors to develop chemoresis-
tance, a comprehensive quantitative model must be used
to describe the interactions of cell resistance mechanisms
and tumor microenvironment during chemotherapy.
Results suggest that the maximum potential of a com-
bined therapy may depend on how each of the drugs
modifies the evolutionary landscape and that a rational
use of these properties may prevent or at least delay
relapse.
Further implications for tumor dynamics and therapy
The last section includes models inspired by the evolu-
tionary mechanisms discussed earlier on, and exploring
their consequences for such specific processes as genome
instability, oscillations in tumor growth and bone remod-
eling in multiple myeloma. Tan and Yan [8] introduce a
new stochastic and state space model of human colon
cancer incorporating multiple pathways. In this state
space model, the stochastic system is represented by a
stochastic model, involving 2 different pathways-the
chromosomal instability pathway and the micro-satellite
instability pathway; the observation, cancer incidence
data, is represented by a statistical model. The model is
applied to fit and analyze the SEER data of human colon
cancers from NCI/NIH. The model not provides more
insights into human colon cancer but also provides useful
guidance for its prevention and control and for prediction
of future cancer cases.
Stamper et al. [9] study evolution of oscillatory dynam-
ics in a model of vascular tumor growth. By analysing a
spatially uniform submodel, they identify regions of
parameter space in which the combination of tumor cell
proliferation and vessel occlusion give rise to sustained
temporal oscillations in the tumor cell population and in
the vessel density. Further, employing a combination of
numerical and analytical techniques, they demonstrate
how the spatio-temporal dynamics of the untreated
tumor may influence its response to chemotherapy.
Ayati et al. [10] analyze a mathematical model of bone
remodeling dynamics for normal bone cell populations
and myeloma bone disease. Multiple myeloma is a hema-
tologic malignancy associated with the development of a
destructive osteolytic bone disease. The model examines
the critical signaling between osteoclasts (bone resorp-
tion) and osteoblasts (bone formation). The therapeutic
effects of targeting both myeloma cells and cells of the
bone marrow microenvironment on these dynamics are
examined.
Cancer is, in some sense, a condensed-time laboratory
of evolution. Dedifferentiated cells form colonies that
survive in hostile environment, and they evolve new met-
abolic circuits and aggression and resistance mecha-
nisms. They also can muster cooperation of fibroblasts
and lymphocytes and attract blood vessels. Modeling of
these phenomena, well underway, will also help under-
stand basic mechanisms of life. Taken together, the
papers in this thematic series illustrate the substantial
progress that occurred over the period of past decade.
Qualitative and quantitative understanding of cancer is a
necessary condition for engineering approaches to fight
it. These latter are still scarce.
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